Elutia (ELUT) Submits CanGarooRM Antibiotic-Eluting Biomatrix for FDA Clearance Dec 18, 2023 08:06AM
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance Dec 18, 2023 08:00AM
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results Nov 13, 2023 04:05PM
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million Nov 9, 2023 08:30AM
Aziyo Biologics (AZYO) Rebrands as Elutia, Changes Ticker to ELUT Sep 6, 2023 04:09PM


Sep 6, 2023 04:05PM Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
Aug 30, 2023 08:30AM Aziyo Biologics (AZYO) Announces Publication of a CanGaroo Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
Aug 30, 2023 08:30AM Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
Aug 14, 2023 04:05PM Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company